Diabetic ketoacidosis in pregnancy - Case series, pathophysiology, and review of the literature.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 28 07 2021
revised: 22 11 2021
accepted: 11 12 2021
pubmed: 31 12 2021
medline: 3 2 2022
entrez: 30 12 2021
Statut: ppublish

Résumé

Diabetic ketoacidosis (DKA) during pregnancy is a life-threatening emergency for both the mother and the fetus. The pathophysiology of DKA in pregnancy has its own characteristics due to multiple factors, such as insulin resistance, accelerated starvation and respiratory alkalosis, thus creating ketosis-prone state, with DKA occurring at milder degrees of hyperglycemia, even in normoglycemic levels, which can result in delayed diagnosis and treatment with potential for adverse metabolic consequences. In this article, we presented 8 clinical cases of DKA during pregnancy. We discuss the spectrum of the clinical picture, the entity of euglycemic DKA vs hyperglycemic DKA, the period of pregnancy in appearance of episode of DKA and triggers of DKA. The treatment of DKA in pregnant women must be started immediately and must be accentuated on intravenous fluids, insulin and electrolyte replacement. DKA in pregnancy may be euglycemic. Prevention, early recognition, immediate hospitalization, and aggressive management remain the cornerstones in DKA management in pregnancy.

Identifiants

pubmed: 34968873
pii: S0301-2115(21)01010-1
doi: 10.1016/j.ejogrb.2021.12.011
pii:
doi:

Substances chimiques

Insulin 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-46

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tamar Eshkoli (T)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer-Sheva, Israel; Endocrinology Unit, Soroka University Medical Center, Beer-Sheva, Israel.

Leonid Barski (L)

Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel. Electronic address: eshkolit@bgu.ac.il.

Yaniv Faingelernt (Y)

Department of Pediatric Medicine, Soroka University Medical Center, Beer-Sheva, Israel.

Alan Jotkowitz (A)

Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel.

Alona Finkel-Oron (A)

Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel.

Dan Schwarzfuchs (D)

Department of Emergency Medicine, Soroka University Medical Center, Beer-Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH